Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 83, 2023 - Issue 3
Submit an article Journal homepage
96
Views
0
CrossRef citations to date
0
Altmetric
Letters

Experiences with measuring parathyroid hormone 1-34 in patients with chronic kidney disease

Sabina Chaudhary Haugea Department of Nephrology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, DenmarkCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6695-7513View further author information
ORCID Icon,
Niklas Rye Jørgensenb Department of Clinical Biochemistry, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark;c Department of Clinical Medicine, University of Copenhagen, Copenhagen, DenmarkORCID Iconhttps://orcid.org/0000-0001-9624-5210View further author information
ORCID Icon &
Ditte Hansena Department of Nephrology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark;c Department of Clinical Medicine, University of Copenhagen, Copenhagen, DenmarkORCID Iconhttps://orcid.org/0000-0003-4929-7901View further author information
ORCID Icon
Pages 204-206 | Received 19 Dec 2022, Accepted 25 Mar 2023, Published online: 11 Apr 2023

References

  • Naylor KL, McArthur E, Leslie WD, et al. The three-year incidence of fracture in chronic kidney disease. Kidney Int. 2014;86(4):810–818.
  • Kidney Disease: improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int. 2017;7(Suppl):1–59.
  • Datta NS, Abou-Samra AB. PTH and PTHrP signaling in osteoblasts. Cell Signal Cell Signal. 2009;21(8):1245–1254.
  • Evenepoel P, Bover J, Ureña Torres P. Ureña torres P. Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int. 2016;90(6):1184–1190.
  • Hodsman AB, Bauer DC, Dempster DW, et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev. 2005;26(5):688–703.
  • Hruska KA, Korkor A, Martin K, et al. Peripheral metabolism of intact parathyroid hormone. Role of liver and kidney and the effect of chronic renal failure. J Clin Invest. 1981;67:885–892.
  • Brossard JH, Cloutier M, Roy L, et al. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values. J Clin Endocrinol Metab. 1996;81(11):3923–3929.
  • Brossard J, Yamamoto LN, D'Amour P. Parathyroid hormone metabolites in renal failure: bioactivity and clinical implications. Semin Dial. 2002;15(3):196–201.
  • Jacobsen AA, Bressendorff I, Nordholm A. Diurnal variation of magnesium and the mineral metabolism in patients with chronic kidney disease. Bone Rep. 2021;15:101130
  • Hansen D, Bressendorff I, Nordholm A, et al. Circadian rhythm of markers of bone turnover in patients with chronic kidney disease. Bone Rep. 2022;16:101593
  • Wesseling-Perry K, Harkins GC, Wang HJ, et al. The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84). J Clin Endocrinol Metab. 2010;95(6):2772–2780.
  • Debowska M, Dai L, Wojcik-Zaluska A, et al. Association between biomarkers of mineral and bone metabolism and removal of calcium and phosphate in hemodialysis. Blood Purif. 2020;49(1-2):71–78.
  • Tomita A, Konagaya Y, Nakagawa H. Urinary adenosine 3’,5’-monophosphate, circulating amino-terminal PTH (1–34) and carboxyl-terminal PTH in hypoparathyroidism. Contrib. Nephrol. 1980;22:59–67.
  • Konagaya Y, Konagaya M, Takatsuki K, et al. Studies of circulating parathyroid hormone in man by a homologous amino-terminal specific radioimmunoassay. JPN J Med. 1984;23(3):199–204.
  • Mollerup C, Bruun E, Hesselfeldt-Nielsen J, et al. Clinical applicability of an amino-terminal radioimmunoassay for determination of parathyroid hormone. Acta Chir Scand. 1988;154(7-8):419–423.
  • Shiraki M, Kawada N, Akiguchi I, et al. 1-34 Human parathyroid hormone radioimmunoassay: properties of antiserum against synthetic 1-34 human parathyroid hormone and its clinical application. Endocr Japon. 1981;28(2):239–244.
  • Goltzman D, Henderson B, Loveridge N. Cytochemical bioassay of parathyroid hormone: characteristics of the assay and analysis of circulating hormonal forms. J Clin Invest. 1980;65(6):1309–1317.
  • Kritmetapak K, Losbanos LA, Hines JM, et al. Chemical characterization and quantification of circulating intact PTH and PTH fragments by High-Resolution mass spectrometry in chronic renal failure. Clin. Chem. 2021;67(6):843–853.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.